Takeda Pharmaceutical TAK
NYSE TAK
$17.86 -0.01 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Profit After Tax (2017 - 2026)

Updated

Takeda Pharmaceutical (TAK) posted Profit After Tax of $1.33 billion for the quarter ended Jun 30, 2026, up 8.8% from $1.22 billion a year earlier but down 1.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Profit After Tax (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Profit After Tax at Takeda Pharmaceutical was $1.94 billion, down 49.6% year-over-year; for the year ended Mar 31, 2026, it was -$880.79 million.

  • In prior years, Takeda Pharmaceutical's Profit After Tax was $1.59 billion in the year ended Mar 31, 2025, -$267.76 million in the year ended Mar 31, 2024, $3.21 billion in the year ended Mar 31, 2023 (-4.0%) and $3.34 billion in the year ended Mar 31, 2022 (-0.6%).
  • Quarterly Profit After Tax has run from a low of -$3.52 billion in the quarter ended Dec 31, 2025 to a high of $2.78 billion in the quarter ended Sep 30, 2025 over five years.
  • The strongest year-over-year quarter for Profit After Tax in the past five years was the quarter ended Sep 30, 2023, with growth of 297.9%; the weakest was the quarter ended Dec 31, 2023, with a decline of 96.6%.
  • According to Business Quant data, Profit After Tax for the three prior quarters was $1.35 billion (quarter ended Mar 31, 2026), -$3.52 billion (quarter ended Dec 31, 2025) and $2.78 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 5.28 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 3.09 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -246.00 Mn
10 Takeda Pharmaceutical 2.58 Bn -23.92 Bn 5.10 Bn 1.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.33 Bn
Mar 31, 2026 1.35 Bn
Dec 31, 2025 -3.52 Bn
Sep 30, 2025 2.78 Bn
Jun 30, 2025 1.22 Bn
Mar 31, 2025 1.26 Bn
Dec 31, 2024 -998.51 Mn
Sep 30, 2024 2.37 Bn
Jun 30, 2024 1.14 Bn
Mar 31, 2024 1.23 Bn
Dec 31, 2023 23.00 Mn
Sep 30, 2023 1.94 Bn
Jun 30, 2023 1.32 Bn
Mar 31, 2023 1.56 Bn
Dec 31, 2022 673.55 Mn
Sep 30, 2022 487.77 Mn
Jun 30, 2022 1.59 Bn
Mar 31, 2022 2.65 Bn
Jun 30, 2021 2.82 Bn
Mar 31, 2021 237.89 Mn
API Access

Takeda Pharmaceutical Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=TAK&period=max&api_key=YOUR_API_KEY